Horizon Season 1997 Episode 1 Psychedelic Science

In the first episode of the 1997 season of Horizon, titled "Psychedelic Science," the focus is on scientific research surrounding the use of psychedelic drugs in treating mental illness. The episode explores the history of psychedelic substances such as LSD, which were initially seen as promising tools for psychiatric treatment in the 1950s and '60s before being widely banned in the '70s.

The episode begins by delving into the experiences of patients who have undergone psychedelic-assisted therapy, including a woman suffering from terminal cancer who expresses gratitude for the relief of anxiety and fear provided by psilocybin mushrooms, and a man who credits LSD with helping him overcome addiction. Researchers involved in these studies believe that psychedelics may offer a valuable avenue for treatment of depression, anxiety, PTSD, and other conditions.

However, the use of these drugs in a clinical setting is a highly controversial topic, as they remain illegal in most countries and are often associated with countercultural movements of the 1960s and '70s. The episode delves into the challenges faced by researchers seeking to obtain funding and approval for their studies, and the risks associated with using potentially dangerous substances in a controlled clinical setting.

One of the key figures in the psychedelic science movement is Dr. Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), which advocates for expanded research into the therapeutic potential of psychedelics. Doblin and other researchers argue that the benefits of these drugs are not purely physical, but also psychological and spiritual. However, the episode also explores concerns that the widespread use of psychedelics could lead to negative side effects or even drug addiction.

Throughout the episode, interviews with doctors, patients, and researchers provide a balanced perspective on the scientific potential and ethical considerations of psychedelic-assisted therapy. It highlights the need for more rigorous research to establish the safety and efficacy of these treatments, and the potential for psychedelics to transform mental health care. Overall, Horizon's "Psychedelic Science" offers a fascinating look at a topic that is still highly controversial and little understood by the general public.